SCHEMBL25979738

SCHEMBL25979738

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3cc(-c5cccc(N(c6ccccc6)c6ccccc6)c5)ccc34)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.37
KMT2A Q03164 6/20 0.37
ALDH1A1 P00352 4/20 0.37
MAPT P10636 3/20 0.37
HPGD P15428 3/20 0.37
LMNA P02545 3/20 0.36
KDM4E B2RXH2 2/20 0.36
GLA P06280 2/20 0.36
ABCG2 Q9UNQ0 2/20 0.36
HCRTR1 O43613 1/20 0.36
PDE5A O76074 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
NTSR1 P30989 1/20 0.34
GAA P10253 1/20 0.34
CYP1A2 P05177 3/20 0.33
CYP3A4 P08684 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25979762 0.97 MAPT (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL26779232 0.97 MAPT (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25979758 0.97 MAPT (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25979480 0.96 MAPT (0.35) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL26779202 0.96 MAPT (0.35) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25979153 0.95 PLA2G2A (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL26779203 0.94 MEN1 (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25979908 0.93 MAPT (0.35) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25979803 0.93 MAPT (0.35) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25979639 0.93 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MEN1 257/4885KMT2A 758/4885ALDH1A1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.